1. Directory
  2. California
  3. San Francisco
  4. Parker Institute for Cancer Immunotherapy
EIN 47-3355381

Parker Institute for Cancer Immunotherapy

IRS 501(c) type
501(c)(3)
Num. employees
92
City
San Francisco
State
California
Year formed
2015
Most recent tax filings
2022-12-01
NTEE code, primary
H00: Medical Research: General
Description
The Parker Institute for Cancer Immunotherapy brings together the best scientists, clinicians and industry partners to build a smarter and more coordinated cancer immunotherapy research effort to save lives.
Total revenues
$32,769,137
2022
Total expenses
$62,241,652
2022
Total assets
$307,154,607
2022
Num. employees
92
2022

Program areas at Parker Institute for Cancer Immunotherapy

Parker Institute for Cancer Immunotherapy (pici) encourages advances in Cancer Immunotherapy research, collaboration, and discovery, and the translation of these advances into cures and treatments for the benefit of patients. To do this, pici conducts its own research and clinical trials and provides its consortium of preeminent hospitals and academic research centers with shared research resources, such as scientific equipment, consumables, bioinformatics analysis, and a specimen biobank. Pici also funds and otherwise supports Cancer Immunotherapy research within its consortium.

Grants made by Parker Institute for Cancer Immunotherapy

GranteeGrant descriptionAmount
Dana-Farber Cancer InstituteSupport Research in Field of Cancer Immunotherapy$10,240,000
Gladstone InstitutesSupport Research in Field of Cancer Immunotherapy$2,563,512
Washington University in St. Louis (Wash. U)Support Research in Field of Cancer Immunotherapy$998,477
...and 10 more grants made

Who funds Parker Institute for Cancer Immunotherapy

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Cancer Research Institute (CRI)Research$750,000
Silicon Valley Community Foundation (SVCF)Health$500,000
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$50,000
...and 5 more grants received

Personnel at Parker Institute for Cancer Immunotherapy

NameTitleCompensation
Frederic PlaChief Operating Officer Through 4 and 15 and 21$377,316
Ute DuganChief Medical Officer$751,934
Tarak ModyChief Business Officer$586,752
Melinda GriffithChief Legal Counsel , Vice President - Strategic$520,279
John ConnollyChief Scientific Officer$854,600
...and 12 more key personnel

Financials for Parker Institute for Cancer Immunotherapy

RevenuesFYE 12/2022
Total grants, contributions, etc.$691,633
Program services$13,501,237
Investment income and dividends$1,676,519
Tax-exempt bond proceeds$0
Royalty revenue$759,535
Net rental income$0
Net gain from sale of non-inventory assets$14,043,373
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$2,096,840
Total revenues$32,769,137

Form 990s for Parker Institute for Cancer Immunotherapy

Fiscal year endingDate received by IRSFormPDF link
2022-122023-11-14990View PDF
2021-122022-11-10990View PDF
2020-122021-11-12990View PDF
2019-122021-04-02990View PDF
2018-122020-01-14990View PDF
...and 3 more Form 990s
Data update history
January 22, 2024
Posted financials
Added Form 990 for fiscal year 2022
January 22, 2024
Updated personnel
Identified 3 new personnel
January 1, 2024
Used new vendors
Identified 6 new vendors, including , , , , , and
December 24, 2023
Received grants
Identified 4 new grant, including a grant for $750,000 from The Leona M and Harry B Helmsley Charitable Trust
November 25, 2023
Posted financials
Added Form 990 for fiscal year 2021
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsHeadquarter / parent organizationsCharities
Issues
HealthDiseases and disordersCancer
Characteristics
Conducts researchOperates internationallyTax deductible donations
General information
Address
1 Letterman Dr D3500
San Francisco, CA 94129
Metro area
San Francisco-Oakland-Berkeley, CA
County
San Francisco County, CA
Website URL
parkerici.org/ 
Phone
(650) 804-7101
Facebook page
ParkerICI 
Twitter profile
@parkerici 
IRS details
EIN
47-3355381
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2015
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H00: Medical Research: General
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Central organization
Free account sign-up

Want updates when Parker Institute for Cancer Immunotherapy has new information, or want to find more organizations like Parker Institute for Cancer Immunotherapy?

Create free Cause IQ account
Cause IQ is a website that helps companies grow, maintain, and serve their nonprofit clients, and helps nonprofits find additional foundation funding. Our data and tools help professionals prospect for nonprofits, research opportunities, benchmark their clients, and enrich existing information.
Nonprofits
Product
Customers
About

© 2024 Nonprofit Metrics LLC
Terms of Service and Privacy Policy